Historical record - last NADAC effective date: 12/18/2019
Product Information
NOREL AD TABLET is a brand product labeled by U.S. Pharmaceutical Corporation, priced at $0.7451 per EA under NDC 52747047570. Its NADAC has been published 369 times since Nov 28, 2013.
Strength
325; 4; 10 mg/1; mg/1; mg/1
Manufacturer
U.S. Pharmaceutical CorporationNDC
52747047570
Classification
Brand
Dosage Form
TABLET, MULTILAYER
Route
ORAL
Effective Date
12/18/2019
Active Ingredients
ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/27/2012
Pharmacological Classes
Price Statistics
The NADAC for NOREL AD TABLET has been published 369 times since Nov 28, 2013, and over the history we have for it it has risen 12.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7451 per EA |
|---|---|
| All-time high | $0.7924 (Nov 13, 2019) |
| All-time low | $0.6046 (Apr 23, 2014) |
| Median price | $0.7268 |
| Average price | $0.7185 |
| Largest weekly change | +10.5% (Jun 18, 2014) |
| Weeks tracked | 369 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+12.0%
Last surveyed Dec 16, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acetaminophen, chlorpheniramine maleate, and phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
U.S. Pharmaceutical Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
acetaminophen, chlorpheniramine maleate, and phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NOREL AD TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NOREL AD TABLET, manufactured by U.S. Pharmaceutical Corporation, is $0.7451 per EA (NDC 52747047570), effective Dec 16, 2020.
How has the price of NOREL AD TABLET changed over time?
Over the history we have for it, the NADAC for NOREL AD TABLET has risen 12.0%. It has been tracked across 369 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NOREL AD TABLET?
Since Nov 28, 2013, the NADAC for NOREL AD TABLET has ranged from a low of $0.6046 (Apr 23, 2014) to a high of $0.7924 (Nov 13, 2019), with a median of $0.7268 per EA.
Are there cheaper alternatives to NOREL AD TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NOREL AD TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NOREL AD TABLET?
NOREL AD TABLET (NDC 52747047570) is labeled by U.S. Pharmaceutical Corporation, and CMS classifies it as a brand product.